Addus HomeCare Corporation (ADUS)
| Market Cap | 2.14B +5.5% |
| Revenue (ttm) | 1.48B +15.9% |
| Net Income | 105.31M +26.9% |
| EPS | 5.71 +26.2% |
| Shares Out | 18.29M |
| PE Ratio | 20.51 |
| Forward PE | 16.24 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 130,607 |
| Open | 119.50 |
| Previous Close | 118.52 |
| Day's Range | 116.91 - 120.35 |
| 52-Week Range | 87.95 - 124.44 |
| Beta | 0.86 |
| Analysts | Buy |
| Price Target | 134.69 (+15.03%) |
| Earnings Date | Nov 2, 2026 |
About ADUS
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal ... [Read more]
Financial Performance
In 2025, Addus HomeCare's revenue was $1.42 billion, an increase of 23.21% compared to the previous year's $1.15 billion. Earnings were $95.91 million, an increase of 30.32%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for ADUS stock is "Buy." The 12-month stock price target is $134.69, which is an increase of 15.03% from the latest price.
News
Addus HomeCare to acquire personal care division of AccentCare for $275M
Addus HomeCare (ADUS) Corporation announced a definitive agreement to acquire the personal care division of AccentCare for an anticipated purchase price, after customary purchase price adjustments, of...
Addus HomeCare Announces a Definitive Agreement to Acquire Personal Care Division of AccentCare
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced a definitive agreement to acquire the personal care division of AccentCare ...
Addus HomeCare downgraded to Neutral at BofA on slowing organic growth
As previously reported, BofA downgraded Addus HomeCare (ADUS) to Neutral from Buy with a price target of $125, down from $140, citing lower EBITDA estimates and a lower multiple due…
Addus HomeCare downgraded to Neutral from Buy at BofA
BofA analyst Joanna Gajuk downgraded Addus HomeCare (ADUS) to Neutral from Buy with a price target of $125, down from $140.
Addus HomeCare to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced that Brian Poff, Executive Vice President and Chief Financial Officer, and ...
Addus HomeCare management to meet virtually with William Blair
Virtual Meeting to be held on August 18 hosted by William Blair.
Addus HomeCare announces departure of Chief Operating Officer Dixon
Addus HomeCare (ADUS) announced that Heather Dixon, President and Chief Operating Officer, is no longer with the Company. Brad Bickham, former President and Chief Operating Officer at Addus, has agree...
Addus HomeCare Announces Departure of Heather Dixon and Return of Brad Bickham as Chief Operating Officer on an Interim Basis
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (the “Company”), a provider of home care services, announced today that Heather Dixon, President and Chief Operating Officer, ...
Addus HomeCare price target raised to $136 from $130 at Stephens
Stephens raised the firm’s price target on Addus HomeCare (ADUS) to $136 from $130 and keeps an Overweight rating on the shares. The firm adjusted estimates following the company’s Q2…
Addus HomeCare price target raised to $134 from $130 at RBC Capital
RBC Capital raised the firm’s price target on Addus HomeCare (ADUS) to $134 from $130 and keeps an Outperform rating on the shares. Addus delivered a solid Q2 driven by…
Addus HomeCare Earnings Call Transcript: Q2 2026
Revenue grew 8% year-over-year to $377.4M, with adjusted EPS up 16% and adjusted EBITDA up 12%. Personal care and hospice segments drove growth, while home health showed sequential improvement. Strong cash flow and reduced debt support ongoing acquisitions and expansion.
Addus HomeCare Earnings release: Q2 2026
Addus HomeCare released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Addus HomeCare Quarterly report: Q2 2026
Addus HomeCare has published its Q2 2026 quarterly earnings report on August 4, 2026.
Addus HomeCare reports Q2 adjusted EPS $1.73, consensus $1.70
Reports Q2 revenue $377.4M, consensus $376.22M. Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “We are extremely pleased with the strong financial and operational...
Addus HomeCare Announces Second Quarter 2026 Financial Results
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter and six months ended June 30, ...
Addus HomeCare Announces Second Quarter 2026 Earnings Release and Conference Call
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the second quarter ended June 30, 2026, o...
Addus HomeCare price target raised to $96 from $92 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Addus HomeCare (ADUS) to $96 from $92 and keeps an Underweight rating on the shares. The firm adjusted targets among…
Addus HomeCare Transcript: AGM 2026
The meeting confirmed a quorum and proceeded with the election of two directors, ratification of the auditor, and advisory approval of executive compensation, all of which passed by majority or plurality vote. Shareholders could submit questions online.
Addus HomeCare Transcript: RBC Capital Markets Global Healthcare Conference 2026
Regulatory changes have minimal impact on PCS growth and acquisition plans, while compliance investments strengthen payer relationships. Operational momentum continues in key states, with technology and Bridge Programs supporting census and admissions growth. M&A activity is robust, and financial outlook remains positive.
Addus HomeCare price target lowered to $92 from $102 at Barclays
Barclays lowered the firm’s price target on Addus HomeCare (ADUS) to $92 from $102 and keeps an Underweight rating on the shares. The Centers for Medicare and Medicaid Services imposed…
Addus HomeCare Transcript: Bank of America Global Healthcare Conference 2026
Sequential census and hours growth continued across major markets, aided by technology adoption and operational efficiencies. Balanced growth between rate and volume is being achieved, with recent acquisitions expanding scale and payer relationships. Regulatory and reimbursement outlooks remain stable, supporting ongoing M&A and segment growth strategies.
Addus HomeCare price target lowered to $142 from $150 at Citizens
Citizens lowered the firm’s price target on Addus HomeCare (ADUS) to $142 from $150 and keeps an Outperform rating on the shares. The firm’s outlook remains constructive, with expectations for…
Addus HomeCare to Participate in Upcoming Investor Conferences in May
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securi...
Addus HomeCare price target lowered to $140 from $147 at BofA
BofA lowered the firm’s price target on Addus HomeCare (ADUS) to $140 from $147 and keeps a Buy rating on the shares. Following the company’s Q1 report, the firm maintains…
Addus HomeCare Earnings Call Transcript: Q1 2026
Revenue grew 7.7% to $363.6M in Q1 2026, with adjusted EPS up 14.1% and strong cash flow supporting debt reduction and M&A. Personal care and hospice segments drove growth, aided by rate increases and operational improvements.